We are looking for:

PhD positions for development of radiopharmaceuticals for radionuclide therapy

2 PhD positions are available for research in a cooperation between the Lab Radiopharmaceutical Research and SCK (Belgian Nuclear Research Centre)

Find more information by clicking on the title below

 Submission deadline of your application : March 27, 2018

Development of 225Ac- and 213Bi-labelled somatostatin analogues with improved tumour to kidney ratio for the treatment of neuroendocrine tumours

 

Development of 161Tb-labelled nanobodies for the treatment of colorectal cancer

Deadline for submissions: As soon as possible, no later than: 01/31/2018 00:00